Addition of ultralow dose naloxone to postoperative morphine PCA: Unchanged analgesia and opioid requirement but decreased incidence of opioid side effects

Pain

Volumn 107, Issue 1-2, 2004, Pages 41-46

  Cepeda, M Soledad ^a   Alvarez, Hernando ^a   Morales, Olga ^a   Carr, Daniel B ^b  

^a Facultad de Medicina   (Colombia)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Analgesia; Gender differences; Morphine; Naloxone; Opioid antagonist; Opioids; Pain relief

Indexed keywords

MORPHINE; NALOXONE; OPIATE;

ADULT; AGED; ANALGESIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFECT; FEMALE; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NAUSEA; PAIN ASSESSMENT; PATIENT SELECTION; POSTOPERATIVE PAIN; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SEDATION; SIDE EFFECT; STATISTICAL SIGNIFICANCE; URINE RETENTION; VOMITING;

EID: 0347355442     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pain.2003.09.011     Document Type: Article

References (23)

1. Carr D.B., Cepeda M.S. Letter to the editor. Pain. 101:2003;211-212.
2. Cepeda M.S., Carr D.B. Women experience more pain and require more morphine than men to achieve a similar degree of postoperative analgesia. Anesth Analg. 2003;. 97:1464-68.
3. Cepeda M.S., Vargas L., Ortegon G., Sanchez M., Carr D.B. Comparative analgesic efficacy of patient-controlled analgesia with ketorolac versus morphine after elective intra-abdominal operations. Anesth Analg. 80:1995;1150-1153.
4. Cepeda M.S., Gonzales F., Granados V., Cuervo R., Carr D.B. Incidence of nausea and vomiting in outpatients undergoing general anesthesia in relation to selection of intraoperative opioid. J Clin Anesth. 8:1996;324-328.
5. Cepeda M.S., Delgado M., Ponce M., Cruz C.A., Carr D.B. Equivalent outcomes during postoperative patient-controlled intravenous analgesia with lidocaine plus morphine versus morphine alone. Anesth Analg. 83:1996;102-106.
6. Cepeda M.S., Diaz J.E., Hernandez V., Daza E., Carr D.B. Music does not reduce alfentanil requirement during patient-controlled analgesia (PCA) use in extracorporeal shock wave lithotripsy for renal stones. J Pain Symptom Manage. 16:1998;382-387.
7. Cepeda M.S., Africano J.M., Manrique A.M., Fragoso W., Carr D.B. The combination of low dose of naloxone and morphine in PCA does not decrease opioid requirements in the postoperative period. Pain. 96:2002;73-79.
8. Cepeda M.S., Farrar J.T., Baumgarten M., Boston R., Carr D.B., Strom B.L. Side effects of opioids during short-term administration: effect of age, gender, and race. Clin Pharmacol Ther. 74:2003;102-112.
9. Cepeda M.S., Africano J.M., Polo R., Alcala R., Carr D.B. What is the change in the pain intensity levels that is meaningful to the patients? Pain. 2003;. 105:151-7.
10. Crain S.M., Shen K.F. Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons. Trends Pharmacol Sci. 11:1990;77-81.
11. Crain S.M., Shen K.F. Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment. Proc Natl Acad Sci USA. 92:1995;10540-10544.
12. Crain S.M., Shen K.F. Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability. Pain. 84:2000;121-131.
13. France C.R., Suchowiecki S. A comparison of diffuse noxious inhibitory controls in men and women. Pain. 81:1999;77-84.
14. Holmes B.B., Fujimoto J.M. Inhibiting a spinal dynorphin A component enhances intrathecal morphine antinociception in mice. Anesth Analg. 77:1993;1166-1173.
15. Joshi G.P., Duffy L., Chehade J., Wesevich J., Gajraj N., Johnson E.R. Effects of prophylactic nalmefene on the incidence of morphine-related side effects in patients receiving intravenous patient-controlled analgesia. Anesthesiology. 90:1999;1007-1011.
16. Kendrick W.D., Woods A.M., Daly M.Y., Birch R.F., DiFazio C. Naloxone versus nalbuphine infusion for prophylaxis of epidural morphine-induced pruritus. Anesth Analg. 82:1996;641-647.
17. McNico E., Horowicz-Mehler N., Fisk R.A., Bennett K., Goudas M., Chew P.W., Lau J., Carr D.B. Management of opioid side effects in cancer-related and chronic noncancer pain - a systematic review. J Pain. 2003;. 4:231-56.
18. Shen K.F., Crain S.M. Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice. Brain Res. 757:1997;176-190.
19. Silverman D.G., Freilich J., Sevarino F.B., Paige D., Preble L., O'C onnor T.Z. Influence of promethazine on symptom-therapy scores for nausea during patient-controlled analgesia with morphine. Anesth Analg. 74:1992;735-738.
20. Ueda H., Fukushima N., Kitao T., Ge M., Takagi H. Low doses of naloxone produce analgesia in the mouse brain by blocking presynaptic autoinhibition of enkephalin release. Neurosci Lett. 65:1986;247-252.
21. Walder A.D., Aitkenhead A.R. Antiemetic efficacy of metoclopramide when included in a patient-controlled analgesia infusion. Anaesthesia. 49:1994;804-806.
22. Zarate E., Mingus M., White P.F., Chiu J.W., Scuderi P., Loskota W., Daneshgari V. The use of transcutaneous acupoint electrical stimulation for preventing nausea and vomiting after laparoscopic surgery. Anesth Analg. 92:2001;629-635.
23. Zeger S.L., Liang K.Y., Albert P.S. Models for longitudinal data: a generalized estimating equation approach. Biometrics. 44:1988;1049-1060.